When do Manufacturers of in vitro diagnostic medical devices have to conform to the IVDR (EU) 2017/746?

Manufacturers of in vitro diagnostic medical devices, currently approved, have a transitional period valid until May 26, 2022 to satisfy the IVDR (EU) 2017/746 requirements. Products already certified by a Notified Body may be placed on the market for a further 2 years under certain conditions. For example, the certificate issued under the IVDD is still valid and subject to surveillance by the Notified Body that issued it and no significant changes have been made to the device.

Considering the complexity of the IVD development process, Manufacturers of these medical devices must act well in advance to be in order when the Regulation on in Vitro Diagnostic Medical Devices (IVDR) will enter into force.

Discover the strategic-regulatory consultancy services Thema

Are you a Manufacturer of in vitro Diagnostic Medical Devices?

Fill out the form!

You will receive our White Paper directly on your inbox: a valuable help to understand the necessary actions to be taken to adapt to the IVDR and to be able to market your IVDR devices throughout Europe.

Name and Surname
Company
Role
Email
Consent to processing of data
in accordance with D. Lgs. 196/2003 adapted to the GDPR 679/16 EU by the D. Lgs. 101/2018, I agree to receive the CONTENT referred to in question and receive the periodic NEWSLETTER INFORMATION Thema S.r.l
Information concerning the processing of personal data